andelic acid (2-hydroxy-2-phenyl acetic acid) and Phenyl alanine (2-amino-3-phenyl propanoic acid) exist in racemic forms. The complexes of mandelic acid and phenyl alanine are having hydroxyl group, acid group and amino group which gives the salt formation due to the protonation of amino group through the formation of covalent bond and weak vanderwaals forces of attraction between acidic hydrogen, basic amino group and hydroxyl groups [1]. The zwitterionic structure of amino acid enhances the formation of salt complex with carboxylic acids. Donor and acceptor concept of hydrogen in the salt helps in the redox activity and the radical scavenging activity of the title compounds [2]. The present study indicates the usefulness of the title compounds having hydroxy substitution and conjugation act as antioxidant material to scavenge the free radicals formed during the metabolic activities in the human body. It is further supported by the electrochemical behaviour of the compounds due to the structure property activity of the title compounds [3][4]. The reactive oxygen species formed during metabolic activities are nullified by the exogenous antioxidant having high antiradical power. The increase in electron donating groups in the title compounds modulate antioxidant capacity and they can be used to fight against oxidative stress diseases like cancer, cardiovascular disorders, neurodegenerative pathologies [5].
AlfaAaser mandelic acid and Nice chemicals Lphenyl alanine were mixed in water in 1:2 and 2:1 ratios respectively. Obtained almost clear solution after agitation at room temperature for 2-3 hours, filtered and kept for slow evaporation at room temperature. Observed the crystals formation after 8 days harvested crystals after 28 days showed homogenous on TLC and confirmed the melting point as 184? The recrystallisation of 1:2 mandelic acid [6] and L-phenyl alanine resulted in the diastereomeric isolation of R-phenyl alanine-S-mandelate [7] which showed homogenous on TLC and has melting point 174? C. Characterisation studies , mass analysis, single crystal XRD studies confirmed the structure of the title compounds and the possession of second order non linear susceptibilities due to non centerosymmetric structure.
The increase in the presence of hydroxyl groups and conjugation in the molecular structure favours the oxidation and reduction activity. It is confirmed by the electrochemical behaviour using cyclic voltammetry and the radical scavenging activity using DPPH for the title compounds.
The molecule of 1,1-diphenyl-2-picryl-hydrazyl (DPPH) is characterised as a stable free radical by virtue of the delocalisation of the spare electron over the molecule as a whole, so that the molecules do not dimerise, as would be the case with most other free radicals. The delocalisation also gives rise to the deep violet colour, characterised by an absorption in methanol solution at 517 nm [8].
When a solution of DPPH is mixed with that of a substance that can donate a hydrogen atom, then this gives rise to the reduced form with the loss of this violet colour (although there would be expected to be a residual pale yellow colour from the picryl group still present). Representing the DPPH radical by Z
? and the donor molecule by AH.
The free radical form reacts with the substance AH
Z ? + AH = ZH + A ? [1]where ZH is the reduced form and A
? is free radical produced in this first step. This latter radical will then undergo further reactions which control the overall stoichiometry, that is, the number of molecules of DPPH reduced (decolorised) by one molecule of the reductant.
The reaction [1] is therefore intended to provide the link with the reactions taking place in an oxidising system, such as the autoxidation of an unsaturated substance; the DPPH molecule Z ? is thus intended to represent the free radicals formed in the system whose activity is to be suppressed by the substance AH.
Non-aqueous media cyclic voltammetry (CV) study using Pt electrodes show the possibility of electrooxidation, acceptor -donor interactions of the title compounds and the starting materials [9][10][11].
The DPPH annihilation activity of free radicals is calculated as % inhibition [12][13][14]. The control Ascorbic acid show the maximum % inhibition compared to the title compounds as shown in Table 1. The maximum antioxidant power is shown by more hydroxyl group containing BMALPA Figure -5. The increase in hydroxyl group substitution in the title compounds, the presence of increase in conjugation increases the % inhibition is indicated in the Figure -6. EC 50 or IC 50 is more for BMALPA compared to RPASMA and BLPAMA. The comparative respective efficient concentration and antiradical power shown by the title compounds is given in the Table 2. The presence of electron donating amino group, hydroxyl group and acidic hydrogen in the title compounds show low oxidation potential due to electrooxidation which corresponds to high antioxidant power [15][16][17].
The electrochemical behaviour of the title compounds and the starting materials are compared using the cyclic voltammetry measurements. Donoracceptor interactions leads to hydrogen bond formation [18,19]. The electrochemical oxidation of the title compounds show higher area under anodic wave form which corresponds to higher antioxidant capacity. The presence of electron donating groups have lower half wave potential, higher antioxidant activity and higher reducing power. In the title compounds the presence of more hydroxyl groups, electron donating groups in BMALPA shows higher antioxidant activity. Radical scavenging activity, antiradical power, structure property activity leads to the high antioxidant activity of the title compounds and can be used as fighting agents to nullify the ROS generated during meabolic activities [20].
Novel organic salt complexes can act as exogenic antioxidants is confirmed from the comparative study of title compounds using radical scavenging DPPH method and electrochemical cyclic voltammetric method. The comparable results from the both methods give optimistic thought to over come the prevailing health issues caused by the present life style of the modern world. The use of starting materials to synthesise the title compounds find many medical applications , constituent to protect the central nervous system the harmless effects are expected for the title compounds in the in-vivo studies.


| Year 2016 | ||
| Volume XVI Issue I Version I | ||
| D D D D ) ( B | respectively. | C, 173? C |
| M |
| Conc | % inhibition | |||
| micro | ||||
| gram | ASCORBIC ACID | RPASMA BLPAMA BMALPA | ||
| 25 | 58.88 | 40.55 | 15.69 | 13.08 |
| 50 | 64.42 | 53.83 | 26.74 | 18.92 |
| 100 | 83.09 | 63.28 | 39.49 | 41.94 |
| 250 | 96.44 | 74.77 | 54.72 | 70.78 |
| SAMPLE | IC 50 | ARP |
| BLPAMA | 206.4 | 0.00485 |
| BMALPA | 140.47 | 0.00712 |
| RPASMA | 151.15 | 0.00662 |